Morio, F. | IICIMED

Morio, F.

Professeur – Praticien Hospitalier

Publications

P306

JAC-Antimicrobial Resistance, 2026, 8, 1.

Global epidemiology of azole resistance in Aspergillus fumigatus.


https://doi.org/10.1093/jacamr/dlaf219

P305

Medical Mycology, 2025, 63, 12.

Multi-fungicide resistance in both clinical and environmental isolates of the human fungal pathogen Aspergillus fumigatus.


https://doi.org/10.1093/mmy/myaf110

P303

npj Antimicrob. Resist., 2025, 3, 99.

Emerging antifungal resistance in Candida parapsilosis: the end of the innocence.


https://doi.org/10.1038/s44259-025-00173-5

P301

J. Med. Mycol. 2025, 101583.

A One Health Perspective on Diutina catenulata: Phenotypic Traits, Stress Sensitivity, and Virulence Across Diverse Isolates.


https://doi.org/10.1016/j.mycmed.2025.101583

P295

Mycoses. 2025, 68, e70051

Antifungal Resistance in Non-fumigatus Aspergillus Species.


https://doi.org/10.1111/myc.70051

P294

Mycopathologia. 2025, 190, 59.

Trichosporon and Antifungal Resistance: Current Knowledge and Gaps.


https://doi.org/10.1007/s11046-025-00969-z

P293

mBio. 2025, e01320-25.

Small pangenome of Candida parapsilosis reflects overall low intraspecific diversity.


https://doi.org/10.1128/mbio.01320-25

P292

Sci. Total Environ. 2025, 1000, 180385.

Agrochemical fungicides as environmental drivers of antifungal resistance.


https://doi.org/10.1016/j.scitotenv.2025.180385

P284

Nat. Commun. 2024, 15, 9190.

Alternative sulphur metabolism in the fungal pathogen Candida parapsilosis.


https://doi.org/10.1038/s41467-024-53442-8

P283

Trends Microbiol. 2024, 32, 1042-1044.

Heteroresistance: a hidden cause behind antifungal prophylaxis failure.


https://doi.org/10.1016/j.tim.2024.09.008

P278

Antimicrob. Agents Chemother. 2024, e0002224.

Precise genome editing underlines the distinct contributions of mutations in ERG11, ERG3, MRR1, and TAC1 genes to antifungal resistance in Candida parapsilosis.


https://doi.org/10.1128/aac.00022-24

P276

Med. Mycol. 2023, 61, myad095.

Atovaquone exposure and Pneumocystis jirovecii cytochrome b mutations: French data and review of the literature. 


https://doi.org/10.1093/mmy/myad095

P266

Microbiol. Resour. Announc. 2023, 12, e0126022. 

Draft Genome Sequence of the Fluconazole-Resistant Yarrowia lipolytica Clinical Isolate CBS 18115.


https://doi.org/10.1128/mra.01260-22

P253

mBio. 2022, e0177722. 

Systematic analysis of copy number variations in the pathogenic yeast Candida parapsilosis identifies a gene amplification in RTA3 that is associated with drug resistance.


https://doi.org/10.1128/mbio.01777-22

P252

Clin. Microbiol. Infect. 2022

Acquired fluconazole resistance and genetic clustering in Diutina (Candida) catenulata from clinical samples.


https://doi.org/10.1016/j.cmi.2022.09.021

P246

Microorganisms. 2022, 10, 104. 

Impact of TR34/L98H, TR46/Y121F/T289A and TR53 alterations in azole‐resistant Aspergillus fumigatus on sterol composition and modifications after In Vitro exposure to itraconazole and voriconazole.


https://doi.org/10.3390/microorganisms10010104

Autres publications scientifiques

PS08

J. Infect. Dis. 2022, 225, 868-880. 

PRONOCYSTIS Study Group. Epidemiology and clinical impact of respiratory cinfections at diagnosis of Pneumocystis jirovecii pneumonia. 


https://doi.org/10.1093/infdis/jiab460

PS07

Antimicrob. Agents Chemother. 2022, 66, e0156321.

Highly conserved gsc1 gene of Pneumocystis jirovecii in patients with or without prior exposure to ehinocandins.


https://doi.org/10.1128/AAC.01563-21

PS06

Parasite. 2022, 29.

Selecting a multiplex PCR panel for accurate molecular diagnosis of intestinal protists: a comparative study of Allplex® (Seegene®), G-DiaParaTrio (Diagenode®), and RIDA®GENE (R-Biopharm®) assays and microscopic examination. 


https://doi.org/10.1051/parasite/2022003

Brevets

Thèse

T27.

Bases moléculaires de la résistance aux azolés chez C. albicans et A. fumigatus.


Nantes, date de soutenance : 5 juillet 2012.